STOK Sale Disclosure
Ticho Barry · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$184.51K
Ticho Barry Chief Medical Officer
STOK
Stoke Therapeutics
STOK
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
STOK daily price context
Close on/before transaction
$26.48
Nov 2, 2026
First close after public filing
$26.07
Nov 5, 2026
Return after filing · so far
+1.8%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,995 shares @ $26.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780088-26-000025
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$189.91K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Stoke Therapeutics, Inc. STOK Current | Sale | Nov 2, 2026 | $184.51K |
| Stoke Therapeutics, Inc. STOK | Sale | Nov 2, 2026 | $5.4K |